There’s nothing more important to stock prices than earnings and expectations for earnings growth. Earnings, or net income, is literally the bottom line.While that’s a principle that plays out in the market in the long-run, it unfortunately isn’t promised in the short-run.Take this chart FactSet’s John Butters updates regularly. It shows the trajectory of the S&P 500 with the trajectory […]
@MarkBartonTVChina’s stock market got wrecked on Friday with the Shanghai Composite index crashing by 7.4%.The red-hot market is now down 19% from its high, which it set on June 12.Some folks may see this as a buying opportunity, but not the analysts at Morgan Stanley.”[T]his is probably not a dip to buy,” Morgan Stanley’s Jonathan Garner said. “In fact, we […]
Sam Ro
Jun. 1, 2015, 11:38 AM
739
There’s nothing more important to stock prices than earnings and expectations for earnings growth. Earnings, or net income, is literally the bottom line.While that’s a principle that plays out in the market in the long-run, it unfortunately doesn’t in the long run.Take this chart from FactSet’s John Butters. It shows the trajectory of the S&P […]
Benchmarks ended higher on Monday following China’s stimulus measures and upbeat earnings results. China’s central bank’s announcement that it would trim its reserve requirement ratio to boost lending and combat slow economic growth was welcomed by investors. Meanwhile, positive first quarter earnings results from Morgan Stanley, Halliburton and Hasbro also added to the bullish sentiment.For a look at the issues […]
Technology
Here’s Why Micron Technology, Inc. (MU) Stock Is Trading Up 9.1%
Following the release of an amended supply agreement with Inotera, Micron Technology stock is trading up by around 9.1% today
MU
By: Joshua GriffinPublished: Feb 10, 2015 at 3:24 pm EST
Micron Technology, Inc. (NASDAQ:MU) is trading up by around 9.1% as of 3:02 PM EST today. The rally in the stock price […]
What Investors Are Looking At In The Stem Cell Sector
By iCELL News on January 14, 2015 · Sector
Stem cell stocks did poorly in 2014.However, many of these companies have catalysts in the first quarter of 2015 that could bring attention to the sector.In anticipation of a Phase 2 clinical update, Brainstorm Cell Therapeutics IncBCLI 1.89%stock rallied nearly 100 percent. The […]
Sam Ro
Jan. 5, 2015, 9:10 AM
5,631
Asset bubbles are notoriously difficult to identify as they are happening. Often times, they become clear only in hindsight.That said, Goldman Sachs’ David Kostin offers this interesting stock market chart in a new note to clients. It’s a favorite of his.It shows the sector composition of the S&P 500 by market cap since 1975. As […]
Biotechs Rally!Biotech stocks were really strong today. BIIB led the group with a $18.59 pop! ALXN added nearly $10. AMGN gained $5.34, erasing yesterday’s loss. JAZZ climed +3%. ILM popped $6.61.At first glance, BTK looks to be healthyBTK has been consolidating for more than a month. Its daily MAs have bunched together. Just yesterday, BTK was look bearish when it […]
SAN FRANCISCO (MarketWatch) — Cyberonics Inc. shares declined in the extended session Monday after the medical device maker said its appeal of a medical reimbursement decision was denied.Cyberonics CYBX, +5.49% shares fell 8.1% to $53.10 on moderate volume after an appeals board supported a 2007 decision by the Centers for Medicare and Medicaid that the company’s pacemaker-like device for treating […]
Source: GlaxoSmithKline via Flickr.When it comes to healthcare events, there is none more important than the JPMorgan Healthcare Conference. Filled with dozens upon dozens of biotech and medical device companies, the JPMorgan Healthcare Conference, coming up in mid-January, is the perfect time for companies to unveil a study or device they’ve been keeping under their thumb for a rainy day.With […]
